Matthew Pratt Whalen - 08 Aug 2024 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Director
Signature
/s/ Matthew Pratt Whalen
Issuer symbol
TELO
Transactions as of
08 Aug 2024
Transactions value $
$0
Form type
3
Filing time
15 Aug 2024, 11:17:06 UTC
Next filing
29 Aug 2024

No securities are beneficially owned.